Defence Therapeutics targets new types of cancer

Curing skin cancer, lymphoma, lung cancer and even pancreatic cancer - the list of promising projects Defence Therapeutics is advancing is long. But despite the wide range of services, Defence Therapeutics' projects go hand in hand. The reason lies in the Accum technology, whose platform approach is now protected by the US Patent Office. Below you can find out about the current status of Defence Therapeutics' projects, where the journey may take us in the coming weeks, and in which area Defence Therapeutics could spring a surprise.

Den vollständigen Artikel lesen ...